METHOD FOR OBTAINING PROTEIN DUE TO USING TRANSLATION SYSTEM OF MITOCHONDRIA Russian patent published in 2003 - IPC

Abstract RU 2201961 C2

FIELD: medicine. SUBSTANCE: method deals with producing viral antigens in vitro due to infecting mitochondria-rich, virus-rich animal organ tissue, including hepatitis B virus (HBV) and cultivating infected tissue by human virus. The method is discovered for producing proteins in vitro due to transfecting mitochondria-rich animal tissue with recombinant vector based upon HBV and cultivating transfected tissue in dynamic system for tissue cultivation. EFFECT: higher efficiency. 23 cl, 1 tbl

Similar patents RU2201961C2

Title Year Author Number
MUTANT POLYMERASES OF HEPATITIS B VIRUS 2012
  • Marten Perrin
  • Silvestr Natali
  • Marshan Zhan-Baptist
RU2625021C2
RECOMBINANT PLASMID DNA PTBI-HBSAG COMPRISING CHIMERIC GENE TBI-HBSAG UNDER CONTROL OF SMALLPOX VACCINE PROMOTER P7,5K AND STRAIN OF RECOMBINANT SMALLPOX VACCINE INDUCING IMMUNE RESPONSE AGAINST HIV AND HUMAN HEPATITIS B IN ANIMAL BODY 2001
  • Shchelkunov S.N.
  • Rjazankin I.A.
  • Ageenko V.A.
  • Ignat'Ev G.M.
  • Babkin I.V.
RU2194075C2
SYSTEMS FOR EXPRESSION OF NEWCASTLE DISEASE VIRUS RECOMBINANT RNA AND VACCINES 1999
  • Garsia-Sastre Adol'Fo
  • Palez Piter
RU2270864C2
HEPATITIS B VIRUS SURFACE ANTIGEN EPITOPE AND USE THEREOF 2011
  • Kim Se-Kho
  • Khong Kvang-Von
  • Shin Jong-Von
  • Chang Ki Khvan
  • Kim Min-Soo
  • Im Dzung-Ae
RU2585525C2
RECOMBINANT Hansenula polymorpha YEAST STRAIN - PRODUCER OF MUTANT HEPATITIS B VIRUS SURFACE ANTIGEN (VERSIONS) 2015
  • Krymskij Mikhail Aleksandrovich
  • Borisov Ivan Andreevich
  • Yakovlev Mikhail Simeonovich
  • Agafonov Mikhail Olegovich
  • Ter-Avanesyan Mikhail Davidovich
  • Suslov Anatolij Petrovich
  • Semenenko Tatyana Anatolevna
RU2586513C1
RECOMBINANT VACCINE FOR PROPHYLAXIS OF HEPATITIS B (VERSIONS) 2015
  • Krymskij Mikhail Aleksandrovich
  • Borisov Ivan Andreevich
  • Jakovlev Mikhail Simeonovich
  • Melnikov Vladimir Alekseevich
RU2603729C2
AGENTS AND METHODS OF TREATING HEPATITIS B VIRUS 2017
  • Protser Ulrike
  • Bauer Tanya
  • Kosinska Anna
  • Myuk-Khejsl Martin
RU2740802C2
RECOMBINANT MODIFIED VIRUS OF VACCINE ANKARA ABLE TO EXPRESS HEPATITIS C VIRUS STRUCTURAL ANTIGENS 2002
  • Zutter Gerd
  • Ehrfle Volker
  • Shtajb Karolin
  • Van Juan'
  • Li Guandi
  • Chzhu Lisin'
RU2270860C2
RNA-CONDUCTOR St10 FOR USE IN THE HIGHLY SPECIFIC STREPTOCOCCUS THERMOPHILUS CRISPR / Cas9 (StCas9) NUCLEASES SYSTEM AND USE OF SAID RNA-CONDUCTOR AND StCas9 PROTEIN TO SUPPRESS HEPATITIS B VIRUS EXPRESSION IN THE HOST CELL AND FOR VIRAL DNA ELIMINATION FROM THE HOST CELL 2018
  • Kostyushev Dmitrij Sergeevich
  • Kostyusheva Anastasiya Pavlovna
  • Chulanov Vladimir Petrovich
  • Chulanov Vladimir Petrovich
RU2694396C1
HEPATITIS C VIRUS (HCV) ASIALOGLYCOPROTEIN, IMMUNOGENIC COMPOSITION, METHOD OF INDUCTION OF IMMUNE RESPONSE, METHOD OF IMMUNE ASSAY 1991
  • Rehlston Robert O.
  • Markus Frehnk
  • Tud'Jum Kent B.
  • Gervehjs Barbara A.
  • Kholl Dzhon A.
RU2175657C2

RU 2 201 961 C2

Authors

Pajk Kie-Khiung

Dates

2003-04-10Published

1997-01-21Filed